Showing results (21-30 of 367) with videos related to
Sort By:
Pageof 37
Reviews in Gastroenterological Disorders|December 22, 2005
Nonsteroidal anti-inflammatory drugs, aspirin, and gastrointestinal prophylaxis: an ounce of preventionJames M ScheimanDrugs|July 28, 2006
Unmet needs in non-steroidal anti-inflammatory drug-induced upper gastrointestinal diseasesJames M ScheimanCleveland Clinic Journal of Medicine|June 28, 2002
Outcomes studies of the gastrointestinal safety of cyclooxygenase-2 inhibitorsJames M ScheimanJournal of Managed Care & Specialty Pharmacy|August 29, 2019
Letter--Assessing the Effectiveness of V-BID ImplementationsBeth Shrosbree, A Mark FendrickThe American Journal of Managed Care|May 15, 2003
Effect of off-label use of oncology drugs on pharmaceutical costs: the rituximab experienceDarren Kocs, A Mark FendrickThe American Journal of Managed Care|May 22, 2020
Expanding coverage for essential care during COVID-19A Mark Fendrick, Beth ShrosbreeThe American Journal of Managed Care|July 19, 2018
Insights on site-of-care cancer research: both quality and cost information are necessary to guide policyKavita Patel, A Mark FendrickThe American Journal of Managed Care|December 21, 2017
Expanding the "safe harbor" in high-deductible health plans: better coverage and lower healthcare costsA Mark Fendrick, Rashna SoonavalaThe American Journal of Managed Care|November 14, 2022
Opportunity after crisis: enhancing value in the COVID-19 reboundDouglas Barthold, A Mark FendrickHealth Services Research|February 17, 2026
Use of High- and Low-Value Care Among Traditional Medicare Beneficiaries With and Without MedigapSungchul Park, A Mark FendrickPageof 37